Related Experiment Video
Updated: May 27, 2026
11:07
Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
Focal therapy for clinically localized prostate cancer
Pablo Marchetti1, Scott Eggener
1Section of Urology, University of Chicago Medical Center, Illinois, USA.
Archivos Espanoles De Urologia
|November 5, 2011
Summary
Focal therapy shows promise for low-risk prostate cancer, but accurate staging and long-term outcomes require further study. Ongoing trials will assess safety, efficacy, and functional impact of these innovative treatments.
Area of Science:
- Oncology
- Urology
- Medical Technology
Background:
- Advances in prostate cancer staging, imaging, and ablation technologies enable focal therapy evaluation.
- Low-risk prostate cancer is increasingly considered for focal treatment approaches.
Purpose of the Study:
- To evaluate the feasibility, reliability, and efficacy of focal therapy for low-risk prostate cancer.
- To address limitations in pre-treatment cancer assessment and post-treatment surveillance.
- To investigate the safety and effectiveness of repeat treatments and their impact on patient function.
Main Methods:
- Formal study and evaluation of focal therapy for prostate cancer.
- Ongoing clinical trials to gather data on new therapeutic approaches.
Main Results:
- Significant limitations persist in accurately determining cancer characteristics before treatment.
- Uncertainty remains regarding optimal post-treatment surveillance and definitions of progression.
- The safety and efficacy of repeat focal or whole-gland treatments are under investigation.
Conclusions:
- Focal therapy represents a developing area for managing low-risk prostate cancer.
- Further research is crucial to overcome current limitations and establish reliable treatment protocols.
- Clinical trials are essential for understanding the long-term oncologic and functional outcomes.
